Arm Sinks 19% in a Week as Intel’s Warning Hits Chip Stocks. Is It a Buy?
Arm Holdings (ARM) fell 19% in a week due to Intel's (INTC) weak outlook, which cited substrate supply issues affecting both companies. Arm's Q2 revenue of $1.44B beat guidance, though royalties grew only 8%. Arm's forward P/E is near its 3-year average, with AGI CPU production sales expected by March.
How this was made
The 30-second read
Why it matters
The earnings release provides fresh guidance and revenue numbers, but the market reaction is dominated by sector‑wide concerns.
Market read
Arm's earnings beat is newsworthy, yet the stock faces pressure from Intel's outlook, making the net impact modestly negative.
What to watch
Arm's upcoming AGI CPU production slated for March may provide a catalyst that offsets short‑term sector weakness.
Background
Arm's earnings beat comes amid a broader chip‑stock sell‑off triggered by Intel's weak Q4 outlook and substrate supply constraints.
Ticker impact
Arm reported Q2 revenue of $1.44B beating the top of its guidance range and provided updated AGI CPU revenue outlook, while Intel's weak outlook triggered a 19% weekly drop in Arm's share price.
likely further downside as investors digest the Intel‑related supply concerns.
Arm's earnings beat is outweighed by sector weakness from Intel's guidance, which directly affects Arm's substrate supply and market sentiment.
Market effects
The chip sector may face broader pressure as Intel's supply shortage signals potential constraints for other designers reliant on the same substrates.
U.S. technology stocks could see modest pullback in the near term.
Limited to semiconductor and AI hardware markets; no immediate macro impact.
Counterpoint
Arm's strong revenue beat and forward P/E near its three‑year average could make it a relative value play if the Intel issue is temporary.
Key entities
- CompanyArm Holdings
Designer of semiconductor IP and AI CPUs.
- CompanyIntel Corporation
Major chipmaker whose supply issues affect Arm.
